Factors Supporting a Sustainable European Biosimilar Medicines Market (GfK report)

| November 22, 2015

article image
Avoid pricing and procurement policies that drive prices to levels that threaten the financial viability of the biosimilar medicines industry and undermine continued investment by the pharmaceutical industry in future innovation (R&D). Thoughtful biosimilar medicines pricing will incentivise manufacturers to continue investing in new biosimilar medicines, thereby giving healthcare systems sustained savings and allowing more patient access to the best possible therapy options.

Spotlight

GRACE DRUGS & PHARMACEUTICALS

Ours is the first company in India to introduce LIQUID FILLED TWO PIECE (Hard Gelatin / HPMC Vegetarian) Capsules. GRACE DRUGS & PHARMACEUTICALS inspite of having its own manufacturing setup at Hyderabad are getting their products requirement sourced from various other locations under their technical supervision spread across various other locations.

OTHER ARTICLES

Merck’s Patient-Centric Clinical Trial Recruiting

Article | March 4, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More

Global Antiviral Drugs Market Growth: Is Antiviral Drug the Best Coronavirus Treatment?

Article | March 4, 2020

The global antiviral drugs market has witnessed a rapid surge in demand due to the ongoing Covid-19 pandemic worldwide. So is antiviral drug the best coronavirus treatment? It is still too early to have that conclusion as many medical research and clinical trials are still trying to find the effectiveness and potential side effects of using antiviral drugs to treat coronavirus. But experts believe that antiviral drug might be the best hope for reduce the coronavirus transmission around the world at this stage. However, due to the current difficult situation of the supply chain in many lockdown countries and regions, there is a global shortage on the antiviral drugs supply. With researchers and manufacturers working hard to find and provide effective coronavirus treatment, it is expected that the global antiviral drugs market will have a significant growth over the near future. Antiviral drugs are a type of medication used specifically for treating viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza.

Read More

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | March 4, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

How Can Medical Cannabis Help to Manage Pain Conditions? – The Cannabis Exchange

Article | March 4, 2020

Pain management is one of the most common reasons for the use of medical cannabis products. However, despite many jurisdictions – including Canada, Germany, and the Netherlands – now allowing the prescription of medical cannabis for this purpose, there remains little ‘high-quality’ evidence to support, or oppose its efficacy. Madden et al. (2018) set out to review the evidence available in order to determine the efficacy of medical cannabis when employed in the management of various forms of musculoskeletal pain. The researchers analysed various studies that assessed the use of cannabinoids in the treatment of arthritis pain; back pain; postoperative pain; and trauma-related pain. It is estimated that up to 30% of the population may suffer from a non-cancer-related pain condition. As such a high percentage of people suffer from these conditions, the development of simple and safe therapies is an essential area of research. This is particularly important as the therapeutic options for people with chronic pain are increasingly limited.

Read More

Spotlight

GRACE DRUGS & PHARMACEUTICALS

Ours is the first company in India to introduce LIQUID FILLED TWO PIECE (Hard Gelatin / HPMC Vegetarian) Capsules. GRACE DRUGS & PHARMACEUTICALS inspite of having its own manufacturing setup at Hyderabad are getting their products requirement sourced from various other locations under their technical supervision spread across various other locations.

Events